CombinatoRx, Incorporated Receives Huntington’s Disease Society Leadership Award

CAMBRIDGE, Mass.--(BUSINESS WIRE)--CombinatoRx, Incorporated (NASDAQ: CRXX) today announced that it has received the Marjorie Guthrie Leadership Award from the Huntington’s Disease Society of America (HDSA) during their 40th Anniversary Guthrie Awards Dinner in New York City to benefit the Woody and Marjorie Guthrie Research fund. Alexis Borisy, President and CEO of CombinatoRx was present to accept the award. The Guthrie Family created the Woody and Marjorie Guthrie Research fund to pay tribute to the legendary folk singer Woody Guthrie, who died from complications associated with Huntington’s disease (HD), and to his widow, Marjorie, who founded the HDSA 40 years ago and worked tirelessly to convince Congress to begin research in the area of HD, and other neurological diseases.

MORE ON THIS TOPIC